摘要
目的分析表柔比星联合紫杉醇对三阴性乳腺癌的治疗效果。方法对48例三阴性乳腺癌患者采取表柔比星联合紫杉醇治疗,分析患者治疗效果。结果患者治疗前肿瘤直径(4.15±2.54)cm,治疗后(1.86±1.86)cm,治疗后FOXA1及BRCA1表达水平降低,P<0.05。结论表柔比星联合紫杉醇治疗三阴性乳腺癌效果显著。
Objective To analyze effect of epirubicin combined paclitaxel in treatment of triple negative breast cancer. Methods 48 cases of triple negative breast cancer patients were treated with epirubicin combined paclitaxel, analysed the therapeutic effect. Results Before treatment, tumor diameter was（4.15±2.54） cm, after treatment, it became（1.86±1.86） cm, FOXA1 and BRCA1 expression levels were significantly decreased after treatment, P〈0. 05. Conclusion Epirubicin combined therapy with paclitaxel to treat triple negative breast cancer has significantly effect.
出处
《中国继续医学教育》
2016年第3期152-153,共2页
China Continuing Medical Education
关键词
表柔比星
紫杉醇
三阴性乳腺癌
Epirubicin
Taxol
Triple negative breast cancer
